extrinsic apoptotic signaling pathway in absence of ligand
about
B cell leukemia/lymphoma 2Insulin-like growth factor 1Interleukin 2Interleukin 4Nerve growth factorInterleukin 1 alphaInterleukin 1 alphaBCL2-associated X proteinFas (TNFRSF6)-associated via death domainBCL2-associated agonist of cell deathKit ligandCaspase 2Interleukin 1 betaFas cell surface death receptorAdaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1BCL2 like 11BCL2 related protein A1BCL2 like 10Forkhead box O3Erb-b2 receptor tyrosine kinase 3BAG cochaperone 3BCL2 family apoptosis regulator BOKIntegrin subunit alpha VBCL2 like 2MCL1 apoptosis regulator, BCL2 family memberEYA transcriptional coactivator and phosphatase 2MAPK interacting serine/threonine kinase 2Lipocalin 2Suppressor of tumorigenicity 20Modulator of apoptosis 1BCL2 like 1Myeloid cell leukemia sequence 1Fas (TNF receptor superfamily member 6)BCL2-related ovarian killerInterleukin 3MAP kinase-interacting serine/threonine kinase 1BCL2-like 11 (apoptosis facilitator)BCL2-like 2B cell leukemia/lymphoma 2 related protein A1aBCL2-like 1
P682
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1MAP-1 is a mitochondrial effector of Bax.Lethal congenital contractural syndrome type 2 (LCCS2) is caused by a mutation in ERBB3 (Her3), a modulator of the phosphatidylinositol-3-kinase/Akt pathwayApoptosis and dependence receptors: a molecular basis for cellular addiction.Cell metabolism: an essential link between cell growth and apoptosis
P921
Q14863583-10D8ED7C-5093-4086-AC1E-6F6F7F9EA6B2Q14863583-24C839F6-BC64-455D-A2B4-19B21DD5FA2EQ14863723-B3FA1C4A-2289-4659-9842-FE747851B858Q14864519-04A501E3-76B5-4BE2-977D-C23A7030EB1BQ14865961-B475840B-AF60-4687-84AD-3CF368702FD2Q14873936-04C45483-5690-4E4E-9F9B-7AEAE594A8C8Q14878193-AE478983-9929-497F-8FBB-5C77A89D3F13Q14878201-129F99AB-E136-4486-89B5-B9EF6F603AE2Q14905404-56A619D5-D552-4547-8FB6-95DCBE2E7F68Q14905404-D10A3719-D8BD-45EE-8B73-425870D6047BQ14907140-22DD06C1-04CD-4CE5-8696-1D517A7BFFD2Q14907709-9528C7AF-A6FF-4D10-8810-45CF3AFBF9B4Q14912447-6699CF60-31F0-4BA9-ABB4-ADE46946CD37Q14913278-6649E97C-6DC2-40A3-B241-86214343F770Q14913278-6CAD2F7F-5178-4603-9758-09C047F833CBQ14916414-085BDCD4-79D4-4445-8798-5A7A3E09F470Q1649375-C8B3A09E-E4B2-4D01-BFA2-FCAC69D1E0A3Q21096456-0A3BC75F-999A-48BF-B4A2-9FFDFF70CA73Q21100273-710C3824-8121-4E2C-8212-549C2AA6875AQ21100281-C5588781-FCFA-4624-973F-CB3996B876C8Q21100305-9F0342BA-ACF5-48A8-9CA0-C35D0C3207D2Q21101484-43106474-009B-4DC2-8965-A0A2D6E51729Q21104746-27D5F669-A435-40B8-82F5-0E7E8A3BE0A7Q21105251-73EF2498-F41D-4FBC-97D5-D6A01D92B415Q21106726-41D17FB8-28B2-4D7E-9EDE-DFF70ADC3586Q21107757-FDC2BA3B-B5D2-4326-AD3E-5CB09CBA07E2Q21109504-0440725C-6005-4CFA-B00C-3D9CB357F85BQ21112678-69F7228C-8D55-4909-B3E5-78297E38FBCCQ21112678-F0812E61-0E6E-4C93-9584-4A51B6C26704Q21114415-7E613F7E-4E88-47F4-AF38-9D72A3A437B4Q21120037-7EC0F4CA-5C4F-4B7F-8D09-D245E0113238Q21120113-31BE2206-4829-49A5-87CB-8C2934FC81CFQ21122150-3B7236D7-EDED-4427-8884-8582C5E105ECQ21132265-225DFD89-CD7E-43B3-B398-A91EDF1B2280Q21173156-6E56B2C2-2CD9-4E03-99D3-912B8ED75FD9Q21173156-CA3AFD65-5168-496D-8881-6A91847DADB2Q21428169-C0191976-9176-470D-8E7D-624D1FFFCE78Q21428169-D3409728-EE39-48FF-93D1-2D8B591BF455Q21494938-726A9B13-5FFD-4507-AFBA-AAF1737A42F7Q21495411-DE23CFA8-3A0F-402F-A849-866129E1DB3A
P682
extrinsic apoptotic signaling pathway in absence of ligand
description
A series of molecular signals ...... xecution phase of apoptosis is
@en
biologisch proces
@nl
name
extrinsic apoptotic signaling pathway in absence of ligand
@en
type
label
extrinsic apoptotic signaling pathway in absence of ligand
@en
altLabel
GO:0097192
@en
extrinsic apoptotic signalling pathway in absence of ligand
@en
prefLabel
extrinsic apoptotic signaling pathway in absence of ligand
@en
P2888
P686
GO:0097192